Andrew Paul Chapman
6Patents
4h-index
9Co-inventors
46Inventor score
Filing activity: Jun 8, 1999 → Jun 18, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7012135B2 | Biological products | Chemistry; Metallurgy | 41 | Expired |
| US7402662B2 | Antibody molecules specific to human tumor necrosis factor alpha | Chemistry; Metallurgy | 12 | Active |
| US8067005B1 | Divalent antibody fragments | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7186820B2 | Production of humanised antibodies to TNFα | Chemistry; Metallurgy | 5 | Expired |
| US7977464B2 | Antibody molecules specific to human tumour necrosis factor alpha | Chemistry; Metallurgy | 2 | Active |
| US7662609B2 | E.coli host cells with modified PhoS/PstS periplasmic phosphate-binding proteins, and method of manufacturing recombinant fabs | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.